Browse the evidence

At rest, the majority of free fatty acids (FFA) taken up by skeletal muscle are not oxidized directly but instead enter an intramuscular lipid pool (likely triglycerides) which serves as the immediate source for oxidation.

When you are resting, your muscles do not burn the fat circulating in your blood directly. Instead, they take that fat and store it internally in small lipid pools, which are then slowly broken down to provide energy. This means your body manages fuel storage and usage separately at rest.

Higher proportions of non-12-hydroxylated bile acids (non-12-OH BAs) are associated with a 'metabolically healthy' phenotype in high-BMI individuals and obesity resistance in mice, whereas higher 12-OH BAs are linked to metabolic dysfunction.

This study suggests that the *type* of bile acids in your body, not just the total amount, may indicate your metabolic health. People with high BMI who have higher levels of 'non-12-OH' bile acids (like UDCA and CDCA) tend to be metabolically healthier. This is a biomarker for research and potential future diagnostics, not a current self-test. Focus on maintaining metabolic health through diet and activity, which may naturally support a favorable bile acid profile.

Direct administration of leucine to the mediobasal hypothalamus (MBH) acutely reduces food intake and body weight by activating a specific hypothalamus-brainstem neural circuit involving POMC, oxytocin, and brainstem neurons.

This research highlights that specific amino acids, particularly leucine, act as direct signals to the brain's energy regulation centers. While this study was conducted on rodents using direct brain injections, it suggests that adequate dietary leucine intake may support natural satiety signaling pathways. For humans, ensuring sufficient high-quality protein (rich in leucine) in meals may help regulate meal size and frequency through these biological mechanisms.

Activation of brown adipose tissue (BAT) via mild cold exposure contributes minimally to total daily energy expenditure in humans, adding only approximately 15–25 kcal/d even in individuals with large, active BAT depots.

Exposing yourself to cold to activate brown fat will burn a negligible amount of extra calories (roughly the size of a few bites of food). Do not rely on cold therapy for weight loss; it is not a substitute for nutrition and exercise.

Interventions tailored to the stages-of-change model (e.g., Transtheoretical Model) do not demonstrate superior effectiveness in promoting health-related behavior change compared to non-stage-based interventions or usual care.

Do not rely on complex stage-assessment tools to tailor health behavior interventions (like smoking cessation or diet plans) expecting better results than standard care. The evidence suggests that standard interventions are just as effective as those meticulously matched to a patient's self-reported 'stage of change'. Focus on delivering effective standard interventions rather than investing resources in complex staging algorithms.

Caloric restriction protects against induced carcinogenesis in mice, but this protective effect is entirely dependent on the Nrf2 pathway; without Nrf2, caloric restriction fails to suppress tumor development.

Caloric restriction is a powerful tool for cancer prevention, but its effectiveness relies on your body's ability to activate specific stress-response genes (Nrf2). If these genes are compromised, the cancer-protective benefits of calorie restriction may be lost, even if other benefits like insulin sensitivity remain.

Caloric restriction extends lifespan and improves insulin sensitivity in mice regardless of whether the Nrf2 pathway is functional.

Caloric restriction improves metabolic health and extends lifespan through mechanisms that do not rely on the Nrf2 stress-response pathway. This suggests that even if your Nrf2 system is compromised, you may still gain longevity and metabolic benefits from calorie restriction.

Common sitting activities such as typing and playing hand-held games can exceed the 1.5 MET threshold for sedentary behavior, while standing still may remain below it, challenging the strict posture-based definition of sedentary behavior.

Don't assume standing is always 'better' than sitting. If you are typing or playing a game, you might be burning more calories than if you were just standing still. To get a real metabolic boost, you need to walk or move, not just stand. Active sitting (like playing motion-controlled games) can also push you out of the 'sedentary' category.

Metabolic reprogramming, specifically aerobic glycolysis and fatty acid synthesis, drives the differentiation and function of proinflammatory Th17 cells, while oxidative phosphorylation and fatty acid oxidation support anti-inflammatory Treg cells, thereby linking energy metabolism to immune balance in metabolic diseases.

Your immune system's inflammatory balance is tied to how your cells produce energy. In metabolic diseases like obesity or diabetes, immune cells shift toward using sugar (glycolysis) to drive inflammation (Th17) or use fat burning (FAO) to support regulation (Treg). Managing metabolic health through diet and exercise can influence this cellular energy balance, potentially helping to restore immune homeostasis.

Elevated baseline serum levels of tyrosine and branched-chain/aromatic amino acids are strongly associated with a higher risk of incident type 2 diabetes in South Asian men, independent of obesity and insulin resistance measures.

For South Asian men, having higher levels of certain amino acids (like tyrosine and branched-chain amino acids) is a strong indicator of increased diabetes risk, even if you are not obese or insulin resistant. This suggests that metabolic health assessments should go beyond standard obesity measures. Regular monitoring of these markers, alongside lifestyle interventions focused on diet and physical activity, may help in early detection and prevention of type 2 diabetes.

African-American prepubertal children exhibit significantly lower insulin clearance and higher insulin secretion compared to American White children, resulting in hyperinsulinemia that is not merely a compensatory response to insulin resistance but involves an upregulated beta-cell function.

This research highlights that metabolic differences exist between racial groups, specifically regarding how insulin is cleared and secreted. For African-American children, these physiological differences may predispose them to higher insulin levels even with similar body composition to white peers. While this is a descriptive finding, it underscores the importance of monitoring metabolic health markers early. Dietary patterns, particularly the ratio of fat to carbohydrates, correlate with these metabolic rates, suggesting that nutritional interventions could potentially modulate these risks.

Dietary fiber interventions in healthy adults do not consistently produce significant increases in total or individual short-chain fatty acid (SCFA) levels, with outcomes strictly dependent on fiber type, dose, and analytical methodology.

Do not assume that taking a generic fiber supplement will automatically boost your short-chain fatty acids. The effect is highly variable and depends on the specific type of fiber (e.g., inulin vs. resistant starch), the dose, and your individual gut microbiome composition. Focus on diverse fiber sources from whole foods rather than expecting a uniform metabolic boost from supplements.

The analytical method used to measure SCFAs (e.g., GC vs. HPLC) significantly influences the detection of statistically significant changes, with GC-based methods on plasma/serum showing more frequent significant changes than HPLC on feces.

When evaluating fiber studies, check the measurement method. Studies using Gas Chromatography (GC) on blood samples are more likely to report significant SCFA changes than those using HPLC on feces, even if the biological effect is similar. This highlights the difficulty in measuring blood SCFAs due to low concentrations.

Conjugated linoleic acid (CLA) supplementation does not significantly influence blood lipid markers (total cholesterol, LDL, HDL, triacylglycerides) or blood pressure in humans, although it may increase C-reactive protein (CRP) without necessarily increasing cardiovascular disease risk.

Do not take CLA for the purpose of improving blood pressure or cholesterol levels. Clinical evidence shows it does not improve these cardiovascular risk markers in humans. Its primary utility remains modest body fat reduction.

Calcium and Vitamin D supplementation alone is often ineffective for improving bone mineral density in IBD patients with established osteoporosis, requiring bisphosphonates or fluoride.

If you have IBD and established osteoporosis, calcium and Vitamin D alone are likely not enough. You probably need stronger medication like bisphosphonates. Ensure you get 1.5g of calcium and 800 IU of Vitamin D daily, but don't rely on them to fix your bone density.

Skeletal muscle acts as an endocrine organ that regulates systemic aging and lifespan through the secretion of myokines (e.g., IL-6, irisin, FGF-21) and metabolic adaptations, rather than solely through mechanical or mass-based effects.

Prioritize resistance training and aerobic exercise not just for muscle size, but to trigger the release of myokines like irisin and IL-6. These chemicals signal your liver, fat, and brain to improve metabolism and resist aging. Consistent movement is a chemical factory for longevity.

Exercise-induced mitochondrial uncoupling in skeletal muscle (via UCP1 overexpression) extends lifespan and reduces age-related diseases by activating AMPK and enhancing antioxidant defenses.

High-intensity or endurance exercise can induce mitochondrial adaptations similar to uncoupling, improving metabolic health. Focus on exercises that challenge your mitochondria.

Myostatin inhibition increases muscle mass but does not protect against age-related sarcopenia or force decline, and may even worsen force development in aging.

Do not rely on myostatin inhibitors for anti-aging. Focus on exercise, which naturally regulates myostatin and improves function without the side effects of genetic manipulation.

Diet restriction increases hypothalamic SIRT1 levels, which activates dorsomedial and lateral hypothalamic nuclei to promote physical activity and maintain body temperature.

Diet restriction triggers a specific brain response (SIRT1 activation) that increases physical activity and maintains body temperature. This is an adaptive survival mechanism, not just a side effect.

SIRT1 upregulates orexin type 2 receptor (OX2R) expression in the hypothalamus, augmenting the response to ghrelin during diet restriction.

During diet restriction, your body increases ghrelin (hunger hormone). SIRT1 helps your brain respond to this by increasing orexin receptors, which drives activity and metabolism.

There is no significant dose-response relationship between the volume, frequency, duration, or pace of running and reduced mortality risk; higher doses do not yield greater benefits than lower doses.

Do not feel pressured to increase your running volume, frequency, or speed to get more health benefits. If you are already running occasionally, you are likely getting the maximum mortality benefit available from running. Focus on consistency rather than intensity or volume.

Inhibition of TXNIP expression or activity improves insulin sensitivity, protects pancreatic beta-cells from apoptosis, and ameliorates metabolic abnormalities in type 2 diabetes and obesity.

Targeting TXNIP is a promising therapeutic strategy for managing Type 2 Diabetes and obesity. Drugs like Metformin, GLP-1 agonists, and potentially repurposed drugs like Verapamil work partly by lowering TXNIP levels. This improves insulin sensitivity and protects pancreatic cells. However, because TXNIP helps maintain blood sugar during fasting, inhibitors must be carefully dosed to avoid hypoglycemia and potential long-term cancer risks associated with its loss.

TXNIP acts as a nutrient sensor in the hypothalamus to regulate energy expenditure and adiposity; its overexpression in Agouti-related protein (AGRP) neurons leads to diet-induced obesity.

Your brain plays a key role in how much you weigh. A protein called TXNIP in your brain acts as a sensor for food intake. When this protein is too high, your body burns less energy and stores more fat. Keeping this protein in check in the brain may help prevent obesity.

SGLT1-mediated glucose uptake is the primary mechanism for early glucose-stimulated GLP-1 and GIP secretion, whereas metabolism-dependent pathways play a lesser role in peak early secretion.

Understanding that your gut senses glucose directly via transporters helps explain why whole foods trigger satiety hormones better than isolated sugars or sweeteners.